CKD 5D Asia—what is common and what is different from the West?
Abstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and outcomes of kidney disease patients worldwide through the development and implementation of global clinical practice guidelines (CPG). To attain this mission, KDIGO has been publishing CPGs since 200...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-09-01
|
| Series: | Renal Replacement Therapy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s41100-018-0175-6 |
| _version_ | 1818534975669010432 |
|---|---|
| author | Kunitoshi Iseki |
| author_facet | Kunitoshi Iseki |
| author_sort | Kunitoshi Iseki |
| collection | DOAJ |
| description | Abstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and outcomes of kidney disease patients worldwide through the development and implementation of global clinical practice guidelines (CPG). To attain this mission, KDIGO has been publishing CPGs since 2008. Implementation of CPGs is very important, in particular for many developing countries in Asia. This review was written after the first implementation summit of “chronic kidney disease (CKD)-mineral bone disorder (MBD) guideline in Asia” which took place on April 28 to 29, 2018, in Tokyo. Prevalence of end-stage renal disease (ESRD) is increasing rapidly in Asia. CKD-MBD is a modifiable risk factor of cardiovascular disease (CVD), bone fracture, and mortality, both non-dialysis-dependent and dialysis patients. Concept of CKD-MBD is a newly developed, and the CKD-MBD CPG was published on 2009 and updated on 2017. Unfortunately, very few evidences are available to recommend for daily practice. Many treatment options are based on expert suggestion. Incidence of ESRD especially diabetes mellitus (DM) is very high in Asian countries. More research is needed, in particular using patient-reported outcomes (PRO). |
| first_indexed | 2024-12-11T18:18:39Z |
| format | Article |
| id | doaj.art-1c33bf54a2c04469acd378f275dc0088 |
| institution | Directory Open Access Journal |
| issn | 2059-1381 |
| language | English |
| last_indexed | 2024-12-11T18:18:39Z |
| publishDate | 2018-09-01 |
| publisher | BMC |
| record_format | Article |
| series | Renal Replacement Therapy |
| spelling | doaj.art-1c33bf54a2c04469acd378f275dc00882022-12-22T00:55:20ZengBMCRenal Replacement Therapy2059-13812018-09-01411510.1186/s41100-018-0175-6CKD 5D Asia—what is common and what is different from the West?Kunitoshi Iseki0Clinical Research Support Center, Nakamura ClinicAbstract The mission of Kidney Disease: Improving Global Outcomes (KDIGO) is to improve the care and outcomes of kidney disease patients worldwide through the development and implementation of global clinical practice guidelines (CPG). To attain this mission, KDIGO has been publishing CPGs since 2008. Implementation of CPGs is very important, in particular for many developing countries in Asia. This review was written after the first implementation summit of “chronic kidney disease (CKD)-mineral bone disorder (MBD) guideline in Asia” which took place on April 28 to 29, 2018, in Tokyo. Prevalence of end-stage renal disease (ESRD) is increasing rapidly in Asia. CKD-MBD is a modifiable risk factor of cardiovascular disease (CVD), bone fracture, and mortality, both non-dialysis-dependent and dialysis patients. Concept of CKD-MBD is a newly developed, and the CKD-MBD CPG was published on 2009 and updated on 2017. Unfortunately, very few evidences are available to recommend for daily practice. Many treatment options are based on expert suggestion. Incidence of ESRD especially diabetes mellitus (DM) is very high in Asian countries. More research is needed, in particular using patient-reported outcomes (PRO).http://link.springer.com/article/10.1186/s41100-018-0175-6SurvivalClinical practice guidelineCKDKDIGOCKD-MBD |
| spellingShingle | Kunitoshi Iseki CKD 5D Asia—what is common and what is different from the West? Renal Replacement Therapy Survival Clinical practice guideline CKD KDIGO CKD-MBD |
| title | CKD 5D Asia—what is common and what is different from the West? |
| title_full | CKD 5D Asia—what is common and what is different from the West? |
| title_fullStr | CKD 5D Asia—what is common and what is different from the West? |
| title_full_unstemmed | CKD 5D Asia—what is common and what is different from the West? |
| title_short | CKD 5D Asia—what is common and what is different from the West? |
| title_sort | ckd 5d asia what is common and what is different from the west |
| topic | Survival Clinical practice guideline CKD KDIGO CKD-MBD |
| url | http://link.springer.com/article/10.1186/s41100-018-0175-6 |
| work_keys_str_mv | AT kunitoshiiseki ckd5dasiawhatiscommonandwhatisdifferentfromthewest |